Literature DB >> 20651213

Evaluation of nonenhancing tumor fraction assessed by dynamic contrast-enhanced MRI subtraction as a predictor of decrease in tumor volume in response to chemoradiotherapy in advanced cervical cancer.

Lorenzo Mannelli1, Andrew J Patterson, Mark Zahra, Andrew N Priest, Martin J Graves, David J Lomas, Li Tee Tan, Robin Crawford, James Brenton, Evis Sala.   

Abstract

OBJECTIVE: In this study, we evaluated the feasibility of using dynamic contrast-enhanced MRI (DCE-MRI) subtracted images as a predictor of a decrease in tumor volume in response to chemoradiotherapy in 13 patients with cervical cancer.
CONCLUSION: This study shows that pretreatment tumor nonenhancing fraction assessed with arterial image subtraction inversely predicts the chemoradiation response in cervical cancer.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20651213     DOI: 10.2214/AJR.09.3437

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  10 in total

Review 1.  Noncontrast functional MRI of the kidneys.

Authors:  Lorenzo Mannelli; Jeffrey H Maki; Sherif F Osman; Hersh Chandarana; David J Lomas; William P Shuman; Ken F Linnau; Douglas E Green; Giacomo Laffi; Miriam Moshiri
Journal:  Curr Urol Rep       Date:  2012-02       Impact factor: 3.092

2.  Robustness of quantitative compressive sensing MRI: the effect of random undersampling patterns on derived parameters for DCE- and DSC-MRI.

Authors:  David S Smith; Xia Li; James V Gambrell; Lori R Arlinghaus; C Chad Quarles; Thomas E Yankeelov; E Brian Welch
Journal:  IEEE Trans Med Imaging       Date:  2011-10-14       Impact factor: 10.048

3.  Tumor radiomic heterogeneity: Multiparametric functional imaging to characterize variability and predict response following cervical cancer radiation therapy.

Authors:  Stephen R Bowen; William T C Yuh; Daniel S Hippe; Wei Wu; Savannah C Partridge; Saba Elias; Guang Jia; Zhibin Huang; George A Sandison; Dennis Nelson; Michael V Knopp; Simon S Lo; Paul E Kinahan; Nina A Mayr
Journal:  J Magn Reson Imaging       Date:  2017-10-16       Impact factor: 4.813

4.  Quantitative effects of using compressed sensing in dynamic contrast enhanced MRI.

Authors:  David S Smith; E Brian Welch; Xia Li; Lori R Arlinghaus; Mary E Loveless; Tatsuki Koyama; John C Gore; Thomas E Yankeelov
Journal:  Phys Med Biol       Date:  2011-07-19       Impact factor: 3.609

5.  DCEMRI.jl: a fast, validated, open source toolkit for dynamic contrast enhanced MRI analysis.

Authors:  David S Smith; Xia Li; Lori R Arlinghaus; Thomas E Yankeelov; E Brian Welch
Journal:  PeerJ       Date:  2015-04-23       Impact factor: 2.984

6.  Evaluating Heterogeneity of Primary Lung Tumor Using Clinical Routine Magnetic Resonance Imaging and a Tumor Heterogeneity Index.

Authors:  Nan Hu; ShaoHan Yin; Qiwen Li; Haoqiang He; Linchang Zhong; Nan-Jie Gong; Jinyu Guo; Peiqiang Cai; Chuanmiao Xie; Hui Liu; Bo Qiu
Journal:  Front Oncol       Date:  2021-01-08       Impact factor: 6.244

7.  Cervical cancer apparent diffusion coefficient values during external beam radiotherapy.

Authors:  Peter de Boer; Stefano Mandija; Anita M Werensteijn-Honingh; Cornelis A T van den Berg; Astrid A C de Leeuw; Ina M Jürgenliemk-Schulz
Journal:  Phys Imaging Radiat Oncol       Date:  2019-03-14

Review 8.  Imaging intratumor heterogeneity: role in therapy response, resistance, and clinical outcome.

Authors:  James P B O'Connor; Chris J Rose; John C Waterton; Richard A D Carano; Geoff J M Parker; Alan Jackson
Journal:  Clin Cancer Res       Date:  2014-11-24       Impact factor: 12.531

9.  Medical imaging in personalised medicine: a white paper of the research committee of the European Society of Radiology (ESR).

Authors: 
Journal:  Insights Imaging       Date:  2015-03-13

10.  DCE-MRI of locally-advanced carcinoma of the uterine cervix: Tofts analysis versus non-model-based analyses.

Authors:  Kjersti V Lund; Trude G Simonsen; Gunnar B Kristensen; Einar K Rofstad
Journal:  Radiat Oncol       Date:  2020-04-15       Impact factor: 3.481

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.